ATE53204T1 - Gereinigte hematoporphyrinabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren. - Google Patents

Gereinigte hematoporphyrinabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren.

Info

Publication number
ATE53204T1
ATE53204T1 AT83903067T AT83903067T ATE53204T1 AT E53204 T1 ATE53204 T1 AT E53204T1 AT 83903067 T AT83903067 T AT 83903067T AT 83903067 T AT83903067 T AT 83903067T AT E53204 T1 ATE53204 T1 AT E53204T1
Authority
AT
Austria
Prior art keywords
tumors
molecular weight
hematoporphyrin
diagnosis
substance
Prior art date
Application number
AT83903067T
Other languages
English (en)
Inventor
Kenneth R Weishaupt
Thomas J Dougherty
William R Potter
Original Assignee
Photofrin Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photofrin Medical Inc filed Critical Photofrin Medical Inc
Application granted granted Critical
Publication of ATE53204T1 publication Critical patent/ATE53204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT83903067T 1982-09-27 1983-09-09 Gereinigte hematoporphyrinabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren. ATE53204T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42464782A 1982-09-27 1982-09-27
US48134583A 1983-04-01 1983-04-01
EP83903067A EP0120054B1 (de) 1982-09-27 1983-09-09 Gereinigte hematoporphyrinabkömmlinge für diagnose und tumorbehandlung sowie verfahren
PCT/US1983/001379 WO1984001382A1 (en) 1982-09-27 1983-09-09 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method

Publications (1)

Publication Number Publication Date
ATE53204T1 true ATE53204T1 (de) 1990-06-15

Family

ID=27026406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83903067T ATE53204T1 (de) 1982-09-27 1983-09-09 Gereinigte hematoporphyrinabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren.

Country Status (10)

Country Link
EP (1) EP0120054B1 (de)
JP (1) JPS60500132A (de)
AT (1) ATE53204T1 (de)
AU (1) AU581840B2 (de)
CA (1) CA1271746A (de)
DE (1) DE3381616D1 (de)
DK (1) DK172284B1 (de)
NL (1) NL940021I2 (de)
NO (1) NO166284C (de)
WO (1) WO1984001382A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
AU589957B2 (en) * 1985-04-30 1989-10-26 Nippon Petrochemicals Company Limited New tetrapyrrole therapeutic agents
US4656186A (en) 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
DE3687399T2 (de) * 1985-10-23 1993-04-29 Nihon Mediphysics Co Ltd Porphyrinderivate, ihre herstellung und verwendung.
US5534506A (en) * 1986-01-02 1996-07-09 University Of Toledo Use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5216012A (en) * 1986-01-02 1993-06-01 University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5051415A (en) * 1986-01-02 1991-09-24 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
ATE87826T1 (de) * 1986-01-02 1993-04-15 Univ Toledo Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen.
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
GB2254417A (en) * 1991-04-05 1992-10-07 Bijan Jouza Photodynamic laser detection for cancer diagnosis
NL9200143A (nl) * 1992-01-27 1993-08-16 Seehof Lab F & E Ges Werkwijze voor de bereiding van een actief middel te gebruiken voor de fotodynamische therapie en voor het vaststellen van een diagnose, therapeutisch middel en diagnosticum dat het actief middel bevat en farmaceutische samenstelling.
RU2128993C1 (ru) * 1996-03-27 1999-04-20 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Фармакологическое средство фотогем для фотодинамической терапии рака
US5948061A (en) 1996-10-29 1999-09-07 Double Click, Inc. Method of delivery, targeting, and measuring advertising over networks
AU8072798A (en) 1997-06-16 1999-01-04 Doubleclick Inc. Method and apparatus for automatic placement of advertising
WO2000008802A2 (en) 1998-08-03 2000-02-17 Doubleclick Inc. Network for distribution of re-targeted advertising
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives

Also Published As

Publication number Publication date
DK261384A (da) 1984-05-25
AU581840B2 (en) 1989-03-09
NO166284B (no) 1991-03-18
JPS60500132A (ja) 1985-01-31
NO842089L (no) 1984-05-25
EP0120054B1 (de) 1990-05-30
DK261384D0 (da) 1984-05-25
WO1984001382A1 (en) 1984-04-12
NL940021I1 (nl) 1997-03-03
EP0120054A4 (de) 1985-04-11
AU2032283A (en) 1984-04-24
NO166284C (no) 1991-06-26
NL940021I2 (nl) 1997-05-01
EP0120054A1 (de) 1984-10-03
DK172284B1 (da) 1998-02-23
DE3381616D1 (de) 1990-07-05
CA1271746A (en) 1990-07-17

Similar Documents

Publication Publication Date Title
DE3381616D1 (de) Gereinigte hemaf 3381400inabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren.
EP0127471B1 (de) Phosphorsäurediester, Salze davon, diese enthaltende Zusammensetzungen und Verfahren zur Herstellung solcher Diester und Salze
US4767753A (en) Methods and compositions for preventing ulcers
EP0090341B1 (de) Spiro(4.(3+n))-2-aza-alkan-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
EP0046953A2 (de) Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
YU202888A (en) Process for producing new derivatives of benzocycloheptene
JPH0825977B2 (ja) Ｎ−（２▲’▼−アミノフエニル）−ベンズアミド誘導体，その製法及びそれを含有する薬剤組成物
ATE1192T1 (de) Verfahren zur herstellung von beta-lactam-derivaten, die so erhaltenen neuen derivate sowie diese derivate enthaltende pharmazeutische zusammensetzungen.
JPS6055506B2 (ja) 新規ω−アミノカルボン酸アミドとその製法
DE2808111A1 (de) Neue dipeptidderivate und deren verwendung zur messung der enzymatischen aktivitaet
GB2053232A (en) Dipeptides their preparation and the medicaments in which they are present
EP0394194B1 (de) Geschützte Aminosäuren und Verfahren zu ihrer Herstellung
DE2730549A1 (de) Peptidderivate und deren herstellung
CH615904A5 (en) Process for the preparation of L-leucine-13-motilin
JPS58203982A (ja) ビタミンｅ−アミノ酸エステル類およびその製造方法
JPS6136227A (ja) アンジオテンシン転換酵素阻害剤
JPH0127079B2 (de)
DE2730524A1 (de) Peptidderivate und deren herstellung
DE2416355A1 (de) Direkte synthese von dopaminaminosaeureamiden
EP0192317B1 (de) Homocarnosin- oder Acylhomocarnosin-Salze
US3769364A (en) Carboxyphenyl esters of propenyl and propadienylphosphonic acids
DE3047596A1 (de) Pharmakologisch aktive dipeptide
JPS60188399A (ja) 新規なヘキサペプチド、その取得方法及びそれを含有する製薬学的組成物
DE2721761A1 (de) Peptidderivate und verfahren zu deren herstellung
SU438655A1 (ru) Способ получени 0,0-ди( - -ациламиноэтил)дитиофосфорных кислот

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time